Stereotaxis
Manufacturing · Missouri, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
710 N Tucker Blvd Ste 110, St. Louis, Mi...Phone Number
(314) 678-6100Website
www.stereotaxis.comRevenue
$31.2 MillionStock Symbol
STXSIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room.Explore more
Stereotaxis Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stereotaxis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Stereotaxis
Product Launch: Get notified when Stereotaxis launches new products
Funding: Get notified immidiatlly once Stereotaxis has new funding data
Click to see if Stereotaxis had a recent Job posting/layoffs
Stereotaxis, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Stereotaxis has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Stereotaxis recently announced quarterly report
Check out if Stereotaxis is spiking on competitors!
Recommended Actions
Find VP level buyers at Stereotaxis
Find 2 more new buyers
Compare Similar Companies to Stereotaxis
Compare insights from companies similar to Stereotaxis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Stereotaxis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Stereotaxis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Stereotaxis.
Stereotaxis financials insights
Gather financial insights about Stereotaxis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$10.2M
2014
Debt
$10M
2016
Share Placement
$24M
2018
Other Financing Round
$10M
2019
Share Placement
$25M
2020
Debt
$2M
Share Placement
$15M
2025
Other Financing Round
$50M
Stereotaxis Tech Stack
A closer look at the technologies used by Stereotaxis
Most Recent Scoops
Person-Based
Healthcare Technology
Person-Based
Product Launch
Person-Based
Product Development, Product Launch
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
Stereotaxis News & Media
Stereotaxis Finalizes Robocath Acquisition - Diagnostic and Interventional Cardiology
Stereotaxis has completed its acquisition of Robocath, a provider of robotic technologies for interventional cardiology and neurointerventions.Stereotaxis completes $45M Robocath acquisition - MassDevice
Stereotaxis announced today that it completed its previously announced acquisition of Robocath for up to $45 million.Stereotaxis Completes Acquisition of Robocath
ST. LOUIS and ROUEN, France, July 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has completed its previously announced acquisition of Robocath, an innovator of robotic technologies for interventional cardiology and neurointerventions.Stereotaxis, Inc. (STXS) Q1 2026 Earnings Call Transcript
Stereotaxis, Inc. (STXS) Q1 2026 Earnings Call May 12, 2026 4:30 PM EDTCompany ParticipantsDavid Fischel - CEO & ChairmanKimberly Peery - Chief...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stereotaxis
Sign Up For FreeTo access detailed company insights
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient c... Read More
